Boston Life Science Venture - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $69,943.98 +3.19%
Ethereum $2,445.20 +0.73%
BNB $567.29 +2.58%
Optimism $1.42 +6.12%
Arbitrum $0.49 +2.70%
Solana $166.98 +4.56%
Polygon $0.30 +3.34%
Cosmos $4.17 +6.23%
Avalanche $24.10 +4.90%

Bitcoin $69,943.98 +3.19%
Ethereum $2,445.20 +0.73%
BNB $567.29 +2.58%
Optimism $1.42 +6.12%
Arbitrum $0.49 +2.70%
Solana $166.98 +4.56%
Polygon $0.30 +3.34%
Cosmos $4.17 +6.23%
Avalanche $24.10 +4.90%

Boston Life Science Venture

investment firm

Summary
Investments
Exits

About

Boston Life Science Venture Co. specializes in seed to late stage, expansion stage, and growth stage.

Taipei,T'ai-pei,Taiwan

Highlights

Details

Operating Status: Active
Investor Type: Venture Capital

Investments

Number of Investments

Number of Lead Investments

5

0

Boston Life Science Venture has made 5 investments. Their most recent investment was on Jul 9, 2008, when ConforMIS raised $14.91M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jul 9, 2008 ConforMIS	Series D	$14.91M	Health Care	—
Sep 26, 2007 GlobeImmune	Series C	$41.20M	Biotechnology	—
Aug 9, 2007 Nereus Pharmaceuticals	Series D	$45M	Biotechnology	—
Apr 11, 2006 Bayhill Therapeutics	Series Unknown	$15.80M	Biopharma	—
May 4, 2005 Bayhill Therapeutics	Series B	$35.40M	Biopharma	—

Exits

Boston Life Science Venture has had 3 exits. Boston Life Science Venture most notable exits include GlobeImmune , ConforMIS

Date	Company Name	Exit Type	Industry
Jul 5, 2016	GlobeImmune	IPO	Biotechnology	Detail
Jul 1, 2015	ConforMIS	IPO	Health Care	Detail
Jan 1, 2012	Nereus Pharmaceuticals	M&A	Biotechnology	Detail